Please login to the form below

Sangamo

This page shows the latest Sangamo news and features for those working in and with pharma, biotech and healthcare.

Gilead signs $3bn-plus gene-editing deal with Sangamo

Gilead signs $3bn-plus gene-editing deal with Sangamo. Will use the platform for new cell-based cancer therapies. ... Kite will be responsible for all development, manufacturing and commercialisation of products under the collaboration, and will be

Latest news

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Buying Bioverativ does give it a stake in advanced approaches for haematological diseases however, as the biotech has an established collaboration with Sangamo Therapeutics looking at genome-editing approaches to beta
Pfizer buys into Sangamo’s motor neuron disease gene therapy

Pfizer buys into Sangamo’ s motor neuron disease gene therapy. The pharma giant will pay $12m upfront and $150m in potential milestones. ... Sangamo’s technology involves introducing a ZFP carrying a repressor sequence into the C9ORF72 gene, to
First patient treated with Sangamo’s gene-editing tech

to doctors at UCSF Benioff Children’s Hospital Oakland, who are running the trial with Sangamo and are led by paediatric gastroenterologist Paul Harmatz. ... The ZFNs enter the cells as inactive DNA instructions in a format designed only for liver
Novartis buys blood disease specialist Selexys

Meanwhile, down the line patients could see potential gene therapy treatments start to appear from the likes of Biogen/Sangamo and Bluebird Bio.
Biogen Idec taps Sangamo for blood disorder drugs

Biogen Idec taps Sangamo for blood disorder drugs. Deal is worth up to $320m. ... Biogen Idec has signed a deal worth up to $320m with Sangamo Biosciences focusing on the development of new drugs for blood disorders.

More from news
Approximately 4 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch table for January 2014

320. Sangamo/Biogen Idec . Collaboration and licence. Development of therapies for haemoglobinopathies using zinc finger genome editing.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Eric Rhodes becomes CEO of ERS Genomics

Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Project Manager, Medical Communications, Oxford: Excellent Salary

Senior Account Manager – Med Comms – Kent: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Medical Writer, e-learning/ training, London: Excellent Salary

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Senior Programme Executive: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editorial Director – Medical Education – Oxford: Negotiable

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Medical Writer: Great salary and bebefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Medical Writer: Great salary and benefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Project Manager, Medical Communications, London: Excellent Salary

Editor – Medical Education Agency – Bucks: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...